Although only one case refers to pulmonary TB-IRIS [occurring after interruption of prior anti-TNF-α treatment (Wallis et al., 2009)], these case reports support the possible benefits of TNF-α blockers in the treatment of (complicated) TB. The gene discussed is TNF; the disease is pulmonary tuberculosis.